Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data
Objective This article aims to assess the reproducibility of Manufacturer and User Facility
Device Experience (MAUDE) data-driven studies by analyzing the data queries used in their …
Device Experience (MAUDE) data-driven studies by analyzing the data queries used in their …
Disparities in health and healthcare: impact of race on resource utilization and costs following transcatheter edge-to-edge repair
Background This study sought to investigate health and healthcare disparities in the
management of severe mitral regurgitation with transcatheter edge-to-edge repair using …
management of severe mitral regurgitation with transcatheter edge-to-edge repair using …
Death Incidents Following Transcatheter Edge-to-Edge Repair (TEER) With the MitraClip Device: Analysis of 10-years Post-marketing Death Reports from the …
XH Sun, Y Zhao, Y Li - medRxiv, 2024 - medrxiv.org
Objective: The MitraClip device (Abbott), an FDA-approved transcatheter apparatus, is
employed for the management of mitral regurgitation (MR) among patients deemed at high …
employed for the management of mitral regurgitation (MR) among patients deemed at high …
[HTML][HTML] Cardiogenic Shock Secondary to Acute Mitral Regurgitation With Nonischemic Etiology Successfully Stabilized by Transcatheter Intervention
J Zhang, D Kalil, G Eubanks, BP Kelley, B Singer… - CASE, 2022 - Elsevier
Cardiogenic shock secondary from severe mitral valve (MV) regurgitation remains one of the
most serious entities in clinical practice, with high mortality and limited options. 1 Data from …
most serious entities in clinical practice, with high mortality and limited options. 1 Data from …